These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2226975)

  • 41. Adverse drug reactions in patients with cardiovascular disease. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2008 Dec; 33(12):701. PubMed ID: 19000585
    [No Abstract]   [Full Text] [Related]  

  • 42. Nanotherapeutic Solutions for Cardiovascular Disease.
    Cooke JP; Atkins J
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):132-133. PubMed ID: 27826365
    [No Abstract]   [Full Text] [Related]  

  • 43. Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
    Rao S; Tan A; Thomas N; Prestidge CA
    J Control Release; 2014 Nov; 193():174-87. PubMed ID: 24852093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative stop or continue? New cardiovascular drugs.
    De Hert SG
    Acta Anaesthesiol Belg; 2001; 52(4):365-76. PubMed ID: 11799569
    [No Abstract]   [Full Text] [Related]  

  • 45. Time to implement the polypill approach.
    Holt S
    N Z Med J; 2009 Jun; 122(1296):88-9. PubMed ID: 19652688
    [No Abstract]   [Full Text] [Related]  

  • 46. The polypill concept.
    Wald NJ; Wald DS
    Postgrad Med J; 2010 May; 86(1015):257-60. PubMed ID: 20448221
    [No Abstract]   [Full Text] [Related]  

  • 47. A novel approach for establishing cardiovascular drug efficacy.
    Heerspink HJ; Grobbee DE; de Zeeuw D
    Nat Rev Drug Discov; 2014 Dec; 13(12):942. PubMed ID: 25398246
    [No Abstract]   [Full Text] [Related]  

  • 48. Reviewing common cardiovascular drugs.
    Nursing; 2002 Mar; 32(3):56-7. PubMed ID: 11902048
    [No Abstract]   [Full Text] [Related]  

  • 49. Why is there more heat than light concerning the polypill?
    Rodgers A; Patel A
    BMJ; 2008 Oct; 337():a2162. PubMed ID: 18936069
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cardiological drugs and the elderly].
    Grand A
    Ann Cardiol Angeiol (Paris); 1997; 46(7):461-8. PubMed ID: 9452781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics.
    Franconi F; Carru C; Spoletini I; Malorni W; Vella S; Mercuro G; Deidda M; Rosano G
    Ther Deliv; 2011 Nov; 2(11):1437-53. PubMed ID: 22826875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generic heart medications.
    Harv Heart Lett; 2012 Nov; 23(3):8. PubMed ID: 23409308
    [No Abstract]   [Full Text] [Related]  

  • 53. Cultural competence: cardiovascular medications.
    Kudzma EC
    Prog Cardiovasc Nurs; 2001; 16(4):152-60, 169. PubMed ID: 11684906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aptamers as candidate therapeutics for cardiovascular indications.
    Keefe AD; Schaub RG
    Curr Opin Pharmacol; 2008 Apr; 8(2):147-52. PubMed ID: 18222730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guest Editor John Cooke Offers Expertise and Insight on Nanotherapeutic Solutions for Cardiovascular Diseases.
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):131. PubMed ID: 27826364
    [No Abstract]   [Full Text] [Related]  

  • 56. Doses of cardiovascular medication in elderly patients with renal impairment.
    Carter BL
    Coron Artery Dis; 1997; 8(8-9):495-8. PubMed ID: 9431476
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardiovascular drugs for the newborn.
    Ward RM; Lugo RA
    Clin Perinatol; 2005 Dec; 32(4):979-97, x. PubMed ID: 16325673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abstracts of the 10th International Congress on Cardiovascular Pharmacotherapy. Kyoto, Japan, 27-31 March 2001.
    Cardiovasc Drugs Ther; 2001 Mar; 15 Suppl 1():1-166. PubMed ID: 11501560
    [No Abstract]   [Full Text] [Related]  

  • 59. Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women.
    Schwartz JB
    Cardiol Rev; 2003; 11(5):275-98. PubMed ID: 12943605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The president's page: target response or target dose.
    Cohn JN
    Cardiovasc Drugs Ther; 2009 Aug; 23(4):337. PubMed ID: 19475501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.